SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 38 filers reported holding ETON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$93,000
-24.4%
21,269
-25.5%
0.00%
-33.3%
Q4 2021$123,000
-20.6%
28,561
-7.4%
0.00%0.0%
Q3 2021$155,00030,8440.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 3,088,100$15,564,0002.91%
AWM Investment Company, Inc. 500,000$2,520,0000.25%
HighVista Strategies LLC 21,517$109,0000.07%
GSA CAPITAL PARTNERS LLP 82,314$415,0000.04%
XTX Topco Ltd 14,652$74,0000.02%
CHICAGO TRUST Co NA 16,700$84,0000.02%
Financial Advisors Network, Inc. 10,633$53,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 100,500$507,0000.01%
Westside Investment Management, Inc. 105,300$3,048,0000.01%
Belvedere Trading LLC 20,829$107,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders